Want to join the conversation?
$PKI 2Q15 Call: On a constant currency basis, revenue grew 8%, consisting of 4% organic growth and 4% from recent acquisitions. While our adjusted earnings per share grew 12%. Through first half of the year, adjusted operating margins have increased 90BP and adjusted EPS is up 15%, both on a constant currency basis.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.